We found that the expression of visfatin was stronger in most primary CRC tissue samples than in their normal counterparts (Figure 1A & 1B), and elevated visfatin expression can be detected in CRC patients at advanced clinical stage [assessed using the tumor node metastasis (TNM) system] (Figure 1C & 1D). The gene discussed is NAMPT; the disease is neoplasm.